Workshop Details

January 7, 2021

DAY 1: VACCINE EFFICACY & SAFETY

KEYNOTE: DR. FLORIAN KRAMMER

January 8, 2021

DAY  2: DISTRIBUTION & PRIORITIZATION

KEYNOTE: TBA

WHERE

Virtual meeting information sent after request for invitation received.

SUMMARY

These workshops will each be 90 minutes in length, each organized around a keynote and panel discussion including participants from government, the private sector, and academia. There will be ample time for questions and discussion during each panel.

We hope that these workshops will generate ideas for collaboration among the DHS University Centers of Excellence as well as with governmental, private, and academic entities.

To learn more please visit the event's primary webpage for more details and for the most up-to-date information.

PURPOSE

The Department of Homeland Security university centers of excellence (COEs) have established a COVID-19 Supply Chain Initiative under the leadership of the CCICADA COE based at Rutgers University. As part of this initiative, CCICADA and the CEEZAD COE based at Kansas State University have organized this series of two workshops on COVID-19 vaccines.

The purpose of these workshops is to address the roll-out of these vaccines and:

1. Identify research challenges and relevant tools and methodologies that might be of help with the current pandemic;
2. Identify important topics for collaborative and interdisciplinary reserach across the COEs, and to foster partnerships involving government, the private sector, and academia.
3. Identify key lessons learned from the current situation that can help us be better prepared for future disasters.

REQUEST FOR INFORMATION

Contact Nicole Clark-Johnson at This email address is being protected from spambots. You need JavaScript enabled to view it.

or Stephanie Hober at This email address is being protected from spambots. You need JavaScript enabled to view it.

Please provide your professional affiliation and email address upon submitting request.

SPONSORED BY

DHS OUP
CCICADA
CEEZAD